You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中旗股份(300575.SZ)擬以所持安和生物股權及對其債權合計作價5626.51萬元取得匯盟生物3.0065%股份
格隆匯 12-21 19:51

格隆匯 12 月 21日丨中旗股份(300575.SZ)公佈,為進一步推進公司優化資產結構,推動業務有效整合,獲得良好長期投資收益,基於控股子公司安徽安和生物科技有限公司(“安和生物”)的經營現狀和市場環境,公司與安和生物另一方股東上海敖合化工科技有限公司(“敖合化工”)協商並達成一致意見,將安和生物100%股權暨公司對安和生物的債權以6950萬元轉讓給山東匯盟生物科技股份有限公司(“匯盟生物”)。匯盟生物以發行約390.67萬股(6950萬元折股,佔匯盟生物此次發行股份後股份總數的3.7137%)股份的方式取得安和生物100%股權暨公司對安和生物的債權。其中,公司以持有的安和生物股權及對安和生物的債權合計作價5626.51萬元,取得匯盟生物約316.27萬股股份(佔匯盟生物此次發行股份後股份總數的3.0065%)。

2020年12月18日,公司召開第二屆董事會第四十四次會議,全體與會董事審議並一致通過了《關於轉讓控股子公司股權暨出售資產並對外投資參股的議案》。2020年12月18日,公司與交易各方在江蘇蘇州簽署了《山東匯盟生物科技股份有限公司與江蘇中旗科技股份有限公司及上海敖合化工科技有限公司之發行股份購買資產協議》(以下稱“三方協議”),確定了前述交易安排。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account